You are currently viewing a placeholder content from Vimeo. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.

More Information
Unblock content Accept required service and unblock content

As 2024 draws to a close, the Tiefenbacher Group wishes you a Happy New Year and likes to share some of the year's highlights with you.

This year we celebrated many achievements: several international launches of prescription medicines, the preparation for Bilastine’s over-the-counter entry in Germany, the renovation of our Hamburg offices, and the construction of new labs and production buildings in Hyderabad, India.

2024, our sustainability efforts have been acknowledged with the EcoVadis Silver Medal on several occasions. Our social projects have not been neglected either: we started our strategic partnership with Pharmacists without Boarders, supported our school in India with several projects, and our employees have spent their social day in charitable institutions in Hamburg. Additionally our team in India spent their social day with collecting donations for the victims of the Rahat flood. And last but not least in December a significant part of our employees have donated a substantial amount for a good cause which got doubled by the management.

Furthermore, we have also been to numerous fairs and events to meet you in person. So we can tell you about our latest product portfolio and how we make pharmaceuticals more affordable, more available, and better than before!

Tiefenbacher Group is already looking very much forward to 2025. In this year, we want to continue to rock our markets by surprising patients with more affordable, more available and better-than-before medicines!

We hope the year 2025 will be as successful and full of unique moments as the past one and we are looking forward to meeting you again in person all over the world!
About Tiefenbacher Group – Pioneering Healthcare since 1963

Tiefenbacher Group is a purpose-driven and 100% family-owned healthcare company providing best-in-class solutions along the entire pharmaceutical value chain. From the initial idea to market access of high-quality medicines around the world: We distribute APIs and develop, produce, and register finished dosage forms (FDFs) including highly potent drugs as well as medical devices. Our purpose is to improve people’s lives by making pharmaceuticals more affordable, more available, and better than ever before.

For further information about TIEFENBACHER GROUP and our solutions for better healthcare and our in-house capabilities to develop and commercialize pharmaceutical products for global markets (including highly potent drugs) please contact us by email at info@tiefenbacher.com or visit us on:  www.tiefenbachergroup.com

Tiefenbacher Pharmaceuticals, a part of Tiefenbacher Group, develops and commercializes generic, value added, and innovative pharmaceuticals as well as medical devices worldwide. We provide over 180+ pharmaceutical products across various therapeutic categories in 10+ dosage forms. With our in-house product development and manufacturing, we can address specific therapeutic needs in unique formulations of prescription drugs (Rx) and over-the-counter (OTC) medicines for global markets (including highly potent drugs).

For more information about our finished dosage forms and healthcare solutions, please contact Tiefenbacher Pharmaceuticals: info@tiefenbacher.com or visit us on: www.tiefenbacher-pharmaceuticals.com